Objective: To assess the potential role for Neuregulin-1 (NRG1) as a systemic endogenous protector in the setting of perinatal inflammatory brain damage. Methods: We measured NRG1-protein and mRNA levels in human umbilical venous endothelial cells (HUVECs) of different gestational ages at various durations of exposure to lipopolysaccharide (LPS). In parallel, we genotyped the donor individuals for SNP8NRG221533, a disease-related single nucleotide polymorphism in the 5 0 region upstream of the NRG1 sequence. Intracellular NRG1 localization was visualized by confocal microscopy. Furthermore we analyzed the relationship between SNP8NRG221533 genotype and neurodevelopmental outcome in children born preterm. Results: We observed a positive dose-response-relationship between NRG1-mRNA and intracellular protein levels with both advancing gestational age and duration of LPS exposure in HUVECs. The presence of allele C at the SNP8NRG221533 locus was associated with an increased cellular production of NRG1 in HUVECs, and with a significantly reduced risk for cerebral palsy and developmental delay in children born preterm. Interpretation: In conclusion, our data indicate that gestational age, duration of LPS exposure, and the SNP8NRG221533 genotype affect NRG1 levels. Our results support the hypothesis that NRG1 may qualify as an endogenous protector during fetal development.
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Introduction
Preterm birth is associated with an increased risk of neonatal brain damage (Ferriero, 2004) and long-term developmental delay (Stephens and Vohr, 2009) . Intrauterine infection leads to inflammatory responses (Dudley, 1997; Dammann et al., 2004; Romero et al., 2006 Romero et al., , 2007 that contribute to prematurity and neonatal morbidity. The umbilical vessel endothelium is one of the first fetal interfaces exposed to inflammatory challenges, e.g. lipopolysaccharides (LPS). Indeed, endothelial cells have a remarkable capacity to respond to stressors (Dauphinee and Karsan, 2006; Magder et al., 2006) . Neuregulins (NRGs) play important roles during fetal brain (Bernstein et al., 2006) , heart (Gassmann et al., 1995) and lung development (Dammann et al., 2003) , and are involved in inflammatory processes (Xu et al., 2004 (Xu et al., , 2005 . Several NRG isoforms (Meyer et al., 1997) are produced by alternative splicing (Wen et al., 1994; Falls, 2003) . One of these, NRG1, appears to help signal the onset of surfactant synthesis in the fetal lung (Dammann et al., 2003) and might qualify as a brain protector in experimental ischemia (Xu et al., 2004 (Xu et al., , 2005 . We have recently suggested that NRG1 might play a role not only in adult (Deadwyler et al., 2000; Gerecke et al., 2004) , but also in neonatal brain disorders (Dammann et al., 2007) .
The role of single nucleotide polymorphisms (SNPs) in inflammation-associated genes, e.g. interleukin (IL)-10, as risk-modulators for neonatal disorders has previously been investigated in a pilot study (Dordelmann et al., 2006; Dammann et al., 2009 ). Now we wanted to expand this scenario to include NRG1 and one of its SNPs (SNP8NRG221533) that has been associated with schizophrenia (Stefansson et al., 2002 (Stefansson et al., , 2003 Abbreviations: BPD, bronchopulmonary dysplasia; CAM, chorioamnionitis; CI, confidence interval; CLD, chronic lung disease; CP, cerebral palsy; cPVL, cystic periventricular leukomalacia; DD, developmental delay; NRG, Neuregulin; OR, odds ratio; PTL, preterm labor; PVE, periventricular echodensity; ROM, rupture of membranes; SGA, small for gestational age.
